XML 21 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 24,570 $ 39,878
Short-term marketable securities 89,024 79,228
Accounts receivable, net 318 298
Prepaid expenses and other current assets 12,039 9,452
Total current assets 125,951 128,856
Marketable securities 90,302 62,771
Property and equipment, net 1,008 1,620
Other assets 3,066 4,158
Total assets 220,327 197,405
Current liabilities:    
Accounts payable 4,690 8,878
Accrued expenses 20,333 19,446
Deferred income 3,890  
Other current liabilities 2,683 2,628
Total current liabilities 31,596 30,952
Other liabilities 4,439 3,074
Deferred income, net of current portion 20,038  
Contingent consideration 8,700 6,200
Total liabilities 64,773 40,226
Stockholders' Equity:    
Preferred stock, $0.00001 par value; 10,000,000 shares authorized and no shares issued or outstanding at December 31, 2024 and December 31, 2023
Common stock, $0.00001 par value; 200,000,000 shares authorized at December 31, 2024 and December 31, 2023; 107,850,124 and 70,894,889 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 1 1
Additional paid-in capital 1,058,317 928,080
Accumulated other comprehensive income (loss) 97 (106)
Accumulated deficit (902,861) (770,796)
Total stockholders' equity 155,554 157,179
Total liabilities and stockholders' equity $ 220,327 $ 197,405